Lataa...
Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients
Multiple sclerosis (MS) is a common neurological disability of the central nervous system. Immune-modulatory therapy with interferon-β (IFN-β) has been used as a first-line treatment to prevent relapses in MS patients. While the therapeutic mechanism of IFN-β has not been fully elucidated, the data...
Tallennettuna:
| Julkaisussa: | Biomed Res Int |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930778/ https://ncbi.nlm.nih.gov/pubmed/31915697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5647902 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|